<DOC>
	<DOCNO>NCT00001560</DOCNO>
	<brief_summary>This protocol present rationale , 25-year historical review , method multidisciplinary , low-risk study individual refer NCI Viral Epidemiology Branch ( VEB ) . Referrals generally unusual type cancer relate condition , know , suspect related virus . Kaposi 's sarcoma two homosexual men evaluate 1981 classic example . These referral case provide basis pilot study generate hypothesis , development protocol formal investigation promise lead , help set priority VEB . A VEB investigator Staff Member NIH Clinical Center , interview subject , performs physical examination , draw blood sample , , appropriate disease virus study , obtain clinically indicated biological specimen , urine , sputum , saliva , tear , semen , Pap smear , cervical , anal , oral , nasal swab . On occasion , relatively non-invasive study may indicate . Skin test conventional , license antigens assessment cellular immunity may perform , skin lesion may biopsied excise . Tumor tissue biopsy may obtain biopsy surgery clinically indicate reason . Otherwise surgery perform , therapy administer . Clinical referral component NCI , NIH , private sector make need . The biological specimen frozen otherwise preserve batch test current assay future assay develop . Such laboratory test perform either VEB 's support laboratory , collaboratively NCI , NIH , extramural laboratory need expertise disease virus study . Occasionally , repeat long-term evaluation require . More often , single evaluation NIH outpatient clinic , either collaborate physician 's office suitable site field , sufficient . The VEB investigator provide counsel relevant virus disease study , interim study result . He make appropriate referral need ( e.g. , Genetic Epidemiology Branch genetic counseling ) . Clinically relevant result VEB investigator 's interpretation result , provide write subject 's primary caregiver . Confidentially information obtain carefully protect . The result study summarized publication peer review literature .</brief_summary>
	<brief_title>Clinical , Laboratory Epidemiologic Pilot Studies Individuals High Risk Viral-Associated Cancers</brief_title>
	<detailed_description>This protocol present rationale , 25-year historical review , method multidisciplinary , low-risk study individual refer NCI Viral Epidemiology Branch ( VEB ) . Referrals generally unusual type cancer relate condition , know , suspect related virus . Kaposi 's sarcoma two homosexual men evaluate 1981 classic example . These referral case provide basis pilot study generate hypothesis , development protocol formal investigation promise lead , help set priority VEB . A VEB investigator Staff Member NIH Clinical Center , interview subject , performs physical examination , draw blood sample , , appropriate disease virus study , obtain clinically indicated biological specimen , urine , sputum , saliva , tear , semen , Pap smear , cervical , anal , oral , nasal swab . On occasion , relatively non-invasive study may indicate . Skin test conventional , license antigens assessment cellular immunity may perform , skin lesion may biopsied excise . Tumor tissue biopsy may obtain biopsy surgery clinically indicate reason . Otherwise surgery perform , therapy administer . Clinical referral component NCI , NIH , private sector make need . The biological specimen frozen otherwise preserve batch test current assay future assay develop . Such laboratory test perform either VEB 's support laboratory , collaboratively NCI , NIH , extramural laboratory need expertise disease virus study . Occasionally , repeat long-term evaluation require . More often , single evaluation NIH outpatient clinic , either collaborate physician 's office suitable site field , sufficient . The VEB investigator provide counsel relevant virus disease study , interim study result . He make appropriate referral need ( e.g. , Genetic Epidemiology Branch genetic counseling ) . Clinically relevant result VEB investigator 's interpretation result , provide write subject 's primary caregiver . Confidentiality information obtain carefully protect . The result study summarized publication peer review literature .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Sarcoma , Kaposi</mesh_term>
	<mesh_term>Tumor Virus Infections</mesh_term>
	<criteria>INCLUSION CRITERIA : Family personal medical history neoplasia unusual type , pattern , number . Known suspect factor ( ) predispose neoplasia , environmental exposure ( particularly immunological virological ) , genetic congenital factor ( Mendelian trait predispose neoplasia , birth defect , chromosomal anomaly ) , unusual demographic feature .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 31, 2011</verification_date>
	<keyword>AIDS</keyword>
	<keyword>Multidisciplinary</keyword>
	<keyword>Leukemia</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>Kaposi 's Sarcoma</keyword>
</DOC>